Capron Dmt Tablet
FDA Label NDC 29978-128

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Capital Pharma for the product Capron Dmt (NDC 29978-128). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding directions, other information, active ingredients (in each tablet), purposes, uses, do not exceed recommended dosage., do not use this product, ask a doctor before use if you have, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.